Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Tagrisso (Osimertinib) Market Growth 2022-2028

  • LP 4952844
  • 90 Pages
  • May 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Tagrisso (Osimertinib) will have significant change from previous year. According to our (LP Information) latest study, the global Tagrisso (Osimertinib) market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Tagrisso (Osimertinib) market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Tagrisso (Osimertinib) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Tagrisso (Osimertinib) market, reaching US$ million by the year 2028. As for the Europe Tagrisso (Osimertinib) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Tagrisso (Osimertinib) players cover AstraZeneca, Incepta Pharmaceuticals Ltd, Lonza AG, and Everest Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Tagrisso (Osimertinib) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

40 mg

80 mg

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Locally Advanced NSCLC

Metastatic NSCLC

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

AstraZeneca

Incepta Pharmaceuticals Ltd

Lonza AG

Everest Pharmaceuticals

Beacon Pharmaceuticals Limited

Drug International Limited

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Tagrisso (Osimertinib) Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Tagrisso (Osimertinib) by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Tagrisso (Osimertinib) by Country/Region, 2017, 2022 & 2028

2.2 Tagrisso (Osimertinib) Segment by Type

2.2.1 40 mg

2.2.2 80 mg

2.3 Tagrisso (Osimertinib) Sales by Type

2.3.1 Global Tagrisso (Osimertinib) Sales Market Share by Type (2017-2022)

2.3.2 Global Tagrisso (Osimertinib) Revenue and Market Share by Type (2017-2022)

2.3.3 Global Tagrisso (Osimertinib) Sale Price by Type (2017-2022)

2.4 Tagrisso (Osimertinib) Segment by Application

2.4.1 Locally Advanced NSCLC

2.4.2 Metastatic NSCLC

2.4.3 Other

2.5 Tagrisso (Osimertinib) Sales by Application

2.5.1 Global Tagrisso (Osimertinib) Sale Market Share by Application (2017-2022)

2.5.2 Global Tagrisso (Osimertinib) Revenue and Market Share by Application (2017-2022)

2.5.3 Global Tagrisso (Osimertinib) Sale Price by Application (2017-2022)

3 Global Tagrisso (Osimertinib) by Company

3.1 Global Tagrisso (Osimertinib) Breakdown Data by Company

3.1.1 Global Tagrisso (Osimertinib) Annual Sales by Company (2020-2022)

3.1.2 Global Tagrisso (Osimertinib) Sales Market Share by Company (2020-2022)

3.2 Global Tagrisso (Osimertinib) Annual Revenue by Company (2020-2022)

3.2.1 Global Tagrisso (Osimertinib) Revenue by Company (2020-2022)

3.2.2 Global Tagrisso (Osimertinib) Revenue Market Share by Company (2020-2022)

3.3 Global Tagrisso (Osimertinib) Sale Price by Company

3.4 Key Manufacturers Tagrisso (Osimertinib) Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Tagrisso (Osimertinib) Product Location Distribution

3.4.2 Players Tagrisso (Osimertinib) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Tagrisso (Osimertinib) by Geographic Region

4.1 World Historic Tagrisso (Osimertinib) Market Size by Geographic Region (2017-2022)

4.1.1 Global Tagrisso (Osimertinib) Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Tagrisso (Osimertinib) Annual Revenue by Geographic Region

4.2 World Historic Tagrisso (Osimertinib) Market Size by Country/Region (2017-2022)

4.2.1 Global Tagrisso (Osimertinib) Annual Sales by Country/Region (2017-2022)

4.2.2 Global Tagrisso (Osimertinib) Annual Revenue by Country/Region

4.3 Americas Tagrisso (Osimertinib) Sales Growth

4.4 APAC Tagrisso (Osimertinib) Sales Growth

4.5 Europe Tagrisso (Osimertinib) Sales Growth

4.6 Middle East & Africa Tagrisso (Osimertinib) Sales Growth

5 Americas

5.1 Americas Tagrisso (Osimertinib) Sales by Country

5.1.1 Americas Tagrisso (Osimertinib) Sales by Country (2017-2022)

5.1.2 Americas Tagrisso (Osimertinib) Revenue by Country (2017-2022)

5.2 Americas Tagrisso (Osimertinib) Sales by Type

5.3 Americas Tagrisso (Osimertinib) Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Tagrisso (Osimertinib) Sales by Region

6.1.1 APAC Tagrisso (Osimertinib) Sales by Region (2017-2022)

6.1.2 APAC Tagrisso (Osimertinib) Revenue by Region (2017-2022)

6.2 APAC Tagrisso (Osimertinib) Sales by Type

6.3 APAC Tagrisso (Osimertinib) Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Tagrisso (Osimertinib) by Country

7.1.1 Europe Tagrisso (Osimertinib) Sales by Country (2017-2022)

7.1.2 Europe Tagrisso (Osimertinib) Revenue by Country (2017-2022)

7.2 Europe Tagrisso (Osimertinib) Sales by Type

7.3 Europe Tagrisso (Osimertinib) Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Tagrisso (Osimertinib) by Country

8.1.1 Middle East & Africa Tagrisso (Osimertinib) Sales by Country (2017-2022)

8.1.2 Middle East & Africa Tagrisso (Osimertinib) Revenue by Country (2017-2022)

8.2 Middle East & Africa Tagrisso (Osimertinib) Sales by Type

8.3 Middle East & Africa Tagrisso (Osimertinib) Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Tagrisso (Osimertinib)

10.3 Manufacturing Process Analysis of Tagrisso (Osimertinib)

10.4 Industry Chain Structure of Tagrisso (Osimertinib)

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Tagrisso (Osimertinib) Distributors

11.3 Tagrisso (Osimertinib) Customer

12 World Forecast Review for Tagrisso (Osimertinib) by Geographic Region

12.1 Global Tagrisso (Osimertinib) Market Size Forecast by Region

12.1.1 Global Tagrisso (Osimertinib) Forecast by Region (2023-2028)

12.1.2 Global Tagrisso (Osimertinib) Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Tagrisso (Osimertinib) Forecast by Type

12.7 Global Tagrisso (Osimertinib) Forecast by Application

13 Key Players Analysis

13.1 AstraZeneca

13.1.1 AstraZeneca Company Information

13.1.2 AstraZeneca Tagrisso (Osimertinib) Product Offered

13.1.3 AstraZeneca Tagrisso (Osimertinib) Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 AstraZeneca Main Business Overview

13.1.5 AstraZeneca Latest Developments

13.2 Incepta Pharmaceuticals Ltd

13.2.1 Incepta Pharmaceuticals Ltd Company Information

13.2.2 Incepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Product Offered

13.2.3 Incepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Incepta Pharmaceuticals Ltd Main Business Overview

13.2.5 Incepta Pharmaceuticals Ltd Latest Developments

13.3 Lonza AG

13.3.1 Lonza AG Company Information

13.3.2 Lonza AG Tagrisso (Osimertinib) Product Offered

13.3.3 Lonza AG Tagrisso (Osimertinib) Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Lonza AG Main Business Overview

13.3.5 Lonza AG Latest Developments

13.4 Everest Pharmaceuticals

13.4.1 Everest Pharmaceuticals Company Information

13.4.2 Everest Pharmaceuticals Tagrisso (Osimertinib) Product Offered

13.4.3 Everest Pharmaceuticals Tagrisso (Osimertinib) Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Everest Pharmaceuticals Main Business Overview

13.4.5 Everest Pharmaceuticals Latest Developments

13.5 Beacon Pharmaceuticals Limited

13.5.1 Beacon Pharmaceuticals Limited Company Information

13.5.2 Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Product Offered

13.5.3 Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Beacon Pharmaceuticals Limited Main Business Overview

13.5.5 Beacon Pharmaceuticals Limited Latest Developments

13.6 Drug International Limited

13.6.1 Drug International Limited Company Information

13.6.2 Drug International Limited Tagrisso (Osimertinib) Product Offered

13.6.3 Drug International Limited Tagrisso (Osimertinib) Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Drug International Limited Main Business Overview

13.6.5 Drug International Limited Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Tagrisso (Osimertinib) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Tagrisso (Osimertinib) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 40 mg

Table 4. Major Players of 80 mg

Table 5. Global Tagrisso (Osimertinib) Sales by Type (2017-2022) & (K Pcs)

Table 6. Global Tagrisso (Osimertinib) Sales Market Share by Type (2017-2022)

Table 7. Global Tagrisso (Osimertinib) Revenue by Type (2017-2022) & ($ million)

Table 8. Global Tagrisso (Osimertinib) Revenue Market Share by Type (2017-2022)

Table 9. Global Tagrisso (Osimertinib) Sale Price by Type (2017-2022) & (US$/Pcs)

Table 10. Global Tagrisso (Osimertinib) Sales by Application (2017-2022) & (K Pcs)

Table 11. Global Tagrisso (Osimertinib) Sales Market Share by Application (2017-2022)

Table 12. Global Tagrisso (Osimertinib) Revenue by Application (2017-2022)

Table 13. Global Tagrisso (Osimertinib) Revenue Market Share by Application (2017-2022)

Table 14. Global Tagrisso (Osimertinib) Sale Price by Application (2017-2022) & (US$/Pcs)

Table 15. Global Tagrisso (Osimertinib) Sales by Company (2020-2022) & (K Pcs)

Table 16. Global Tagrisso (Osimertinib) Sales Market Share by Company (2020-2022)

Table 17. Global Tagrisso (Osimertinib) Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Tagrisso (Osimertinib) Revenue Market Share by Company (2020-2022)

Table 19. Global Tagrisso (Osimertinib) Sale Price by Company (2020-2022) & (US$/Pcs)

Table 20. Key Manufacturers Tagrisso (Osimertinib) Producing Area Distribution and Sales Area

Table 21. Players Tagrisso (Osimertinib) Products Offered

Table 22. Tagrisso (Osimertinib) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Tagrisso (Osimertinib) Sales by Geographic Region (2017-2022) & (K Pcs)

Table 26. Global Tagrisso (Osimertinib) Sales Market Share Geographic Region (2017-2022)

Table 27. Global Tagrisso (Osimertinib) Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Tagrisso (Osimertinib) Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Tagrisso (Osimertinib) Sales by Country/Region (2017-2022) & (K Pcs)

Table 30. Global Tagrisso (Osimertinib) Sales Market Share by Country/Region (2017-2022)

Table 31. Global Tagrisso (Osimertinib) Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Tagrisso (Osimertinib) Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Tagrisso (Osimertinib) Sales by Country (2017-2022) & (K Pcs)

Table 34. Americas Tagrisso (Osimertinib) Sales Market Share by Country (2017-2022)

Table 35. Americas Tagrisso (Osimertinib) Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Tagrisso (Osimertinib) Revenue Market Share by Country (2017-2022)

Table 37. Americas Tagrisso (Osimertinib) Sales by Type (2017-2022) & (K Pcs)

Table 38. Americas Tagrisso (Osimertinib) Sales Market Share by Type (2017-2022)

Table 39. Americas Tagrisso (Osimertinib) Sales by Application (2017-2022) & (K Pcs)

Table 40. Americas Tagrisso (Osimertinib) Sales Market Share by Application (2017-2022)

Table 41. APAC Tagrisso (Osimertinib) Sales by Region (2017-2022) & (K Pcs)

Table 42. APAC Tagrisso (Osimertinib) Sales Market Share by Region (2017-2022)

Table 43. APAC Tagrisso (Osimertinib) Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Tagrisso (Osimertinib) Revenue Market Share by Region (2017-2022)

Table 45. APAC Tagrisso (Osimertinib) Sales by Type (2017-2022) & (K Pcs)

Table 46. APAC Tagrisso (Osimertinib) Sales Market Share by Type (2017-2022)

Table 47. APAC Tagrisso (Osimertinib) Sales by Application (2017-2022) & (K Pcs)

Table 48. APAC Tagrisso (Osimertinib) Sales Market Share by Application (2017-2022)

Table 49. Europe Tagrisso (Osimertinib) Sales by Country (2017-2022) & (K Pcs)

Table 50. Europe Tagrisso (Osimertinib) Sales Market Share by Country (2017-2022)

Table 51. Europe Tagrisso (Osimertinib) Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Tagrisso (Osimertinib) Revenue Market Share by Country (2017-2022)

Table 53. Europe Tagrisso (Osimertinib) Sales by Type (2017-2022) & (K Pcs)

Table 54. Europe Tagrisso (Osimertinib) Sales Market Share by Type (2017-2022)

Table 55. Europe Tagrisso (Osimertinib) Sales by Application (2017-2022) & (K Pcs)

Table 56. Europe Tagrisso (Osimertinib) Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Tagrisso (Osimertinib) Sales by Country (2017-2022) & (K Pcs)

Table 58. Middle East & Africa Tagrisso (Osimertinib) Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Tagrisso (Osimertinib) Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Tagrisso (Osimertinib) Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Tagrisso (Osimertinib) Sales by Type (2017-2022) & (K Pcs)

Table 62. Middle East & Africa Tagrisso (Osimertinib) Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Tagrisso (Osimertinib) Sales by Application (2017-2022) & (K Pcs)

Table 64. Middle East & Africa Tagrisso (Osimertinib) Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Tagrisso (Osimertinib)

Table 66. Key Market Challenges & Risks of Tagrisso (Osimertinib)

Table 67. Key Industry Trends of Tagrisso (Osimertinib)

Table 68. Tagrisso (Osimertinib) Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Tagrisso (Osimertinib) Distributors List

Table 71. Tagrisso (Osimertinib) Customer List

Table 72. Global Tagrisso (Osimertinib) Sales Forecast by Region (2023-2028) & (K Pcs)

Table 73. Global Tagrisso (Osimertinib) Sales Market Forecast by Region

Table 74. Global Tagrisso (Osimertinib) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Tagrisso (Osimertinib) Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Tagrisso (Osimertinib) Sales Forecast by Country (2023-2028) & (K Pcs)

Table 77. Americas Tagrisso (Osimertinib) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Tagrisso (Osimertinib) Sales Forecast by Region (2023-2028) & (K Pcs)

Table 79. APAC Tagrisso (Osimertinib) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Tagrisso (Osimertinib) Sales Forecast by Country (2023-2028) & (K Pcs)

Table 81. Europe Tagrisso (Osimertinib) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Tagrisso (Osimertinib) Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Middle East & Africa Tagrisso (Osimertinib) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Tagrisso (Osimertinib) Sales Forecast by Type (2023-2028) & (K Pcs)

Table 85. Global Tagrisso (Osimertinib) Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Tagrisso (Osimertinib) Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Tagrisso (Osimertinib) Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Tagrisso (Osimertinib) Sales Forecast by Application (2023-2028) & (K Pcs)

Table 89. Global Tagrisso (Osimertinib) Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Tagrisso (Osimertinib) Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Tagrisso (Osimertinib) Revenue Market Share Forecast by Application (2023-2028)

Table 92. AstraZeneca Basic Information, Tagrisso (Osimertinib) Manufacturing Base, Sales Area and Its Competitors

Table 93. AstraZeneca Tagrisso (Osimertinib) Product Offered

Table 94. AstraZeneca Tagrisso (Osimertinib) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)

Table 95. AstraZeneca Main Business

Table 96. AstraZeneca Latest Developments

Table 97. Incepta Pharmaceuticals Ltd Basic Information, Tagrisso (Osimertinib) Manufacturing Base, Sales Area and Its Competitors

Table 98. Incepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Product Offered

Table 99. Incepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)

Table 100. Incepta Pharmaceuticals Ltd Main Business

Table 101. Incepta Pharmaceuticals Ltd Latest Developments

Table 102. Lonza AG Basic Information, Tagrisso (Osimertinib) Manufacturing Base, Sales Area and Its Competitors

Table 103. Lonza AG Tagrisso (Osimertinib) Product Offered

Table 104. Lonza AG Tagrisso (Osimertinib) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)

Table 105. Lonza AG Main Business

Table 106. Lonza AG Latest Developments

Table 107. Everest Pharmaceuticals Basic Information, Tagrisso (Osimertinib) Manufacturing Base, Sales Area and Its Competitors

Table 108. Everest Pharmaceuticals Tagrisso (Osimertinib) Product Offered

Table 109. Everest Pharmaceuticals Tagrisso (Osimertinib) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)

Table 110. Everest Pharmaceuticals Main Business

Table 111. Everest Pharmaceuticals Latest Developments

Table 112. Beacon Pharmaceuticals Limited Basic Information, Tagrisso (Osimertinib) Manufacturing Base, Sales Area and Its Competitors

Table 113. Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Product Offered

Table 114. Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)

Table 115. Beacon Pharmaceuticals Limited Main Business

Table 116. Beacon Pharmaceuticals Limited Latest Developments

Table 117. Drug International Limited Basic Information, Tagrisso (Osimertinib) Manufacturing Base, Sales Area and Its Competitors

Table 118. Drug International Limited Tagrisso (Osimertinib) Product Offered

Table 119. Drug International Limited Tagrisso (Osimertinib) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)

Table 120. Drug International Limited Main Business

Table 121. Drug International Limited Latest Developments

List of Figures

Figure 1. Picture of Tagrisso (Osimertinib)

Figure 2. Tagrisso (Osimertinib) Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Tagrisso (Osimertinib) Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Tagrisso (Osimertinib) Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Tagrisso (Osimertinib) Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 40 mg

Figure 10. Product Picture of 80 mg

Figure 11. Global Tagrisso (Osimertinib) Sales Market Share by Type in 2021

Figure 12. Global Tagrisso (Osimertinib) Revenue Market Share by Type (2017-2022)

Figure 13. Tagrisso (Osimertinib) Consumed in Locally Advanced NSCLC

Figure 14. Global Tagrisso (Osimertinib) Market: Locally Advanced NSCLC (2017-2022) & (K Pcs)

Figure 15. Tagrisso (Osimertinib) Consumed in Metastatic NSCLC

Figure 16. Global Tagrisso (Osimertinib) Market: Metastatic NSCLC (2017-2022) & (K Pcs)

Figure 17. Tagrisso (Osimertinib) Consumed in Other

Figure 18. Global Tagrisso (Osimertinib) Market: Other (2017-2022) & (K Pcs)

Figure 19. Global Tagrisso (Osimertinib) Sales Market Share by Application (2017-2022)

Figure 20. Global Tagrisso (Osimertinib) Revenue Market Share by Application in 2021

Figure 21. Tagrisso (Osimertinib) Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Tagrisso (Osimertinib) Revenue Market Share by Company in 2021

Figure 23. Global Tagrisso (Osimertinib) Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Tagrisso (Osimertinib) Revenue Market Share by Geographic Region in 2021

Figure 25. Global Tagrisso (Osimertinib) Sales Market Share by Region (2017-2022)

Figure 26. Global Tagrisso (Osimertinib) Revenue Market Share by Country/Region in 2021

Figure 27. Americas Tagrisso (Osimertinib) Sales 2017-2022 (K Pcs)

Figure 28. Americas Tagrisso (Osimertinib) Revenue 2017-2022 ($ Millions)

Figure 29. APAC Tagrisso (Osimertinib) Sales 2017-2022 (K Pcs)

Figure 30. APAC Tagrisso (Osimertinib) Revenue 2017-2022 ($ Millions)

Figure 31. Europe Tagrisso (Osimertinib) Sales 2017-2022 (K Pcs)

Figure 32. Europe Tagrisso (Osimertinib) Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Tagrisso (Osimertinib) Sales 2017-2022 (K Pcs)

Figure 34. Middle East & Africa Tagrisso (Osimertinib) Revenue 2017-2022 ($ Millions)

Figure 35. Americas Tagrisso (Osimertinib) Sales Market Share by Country in 2021

Figure 36. Americas Tagrisso (Osimertinib) Revenue Market Share by Country in 2021

Figure 37. United States Tagrisso (Osimertinib) Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Tagrisso (Osimertinib) Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Tagrisso (Osimertinib) Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Tagrisso (Osimertinib) Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Tagrisso (Osimertinib) Sales Market Share by Region in 2021

Figure 42. APAC Tagrisso (Osimertinib) Revenue Market Share by Regions in 2021

Figure 43. China Tagrisso (Osimertinib) Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Tagrisso (Osimertinib) Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Tagrisso (Osimertinib) Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Tagrisso (Osimertinib) Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Tagrisso (Osimertinib) Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Tagrisso (Osimertinib) Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Tagrisso (Osimertinib) Sales Market Share by Country in 2021

Figure 50. Europe Tagrisso (Osimertinib) Revenue Market Share by Country in 2021

Figure 51. Germany Tagrisso (Osimertinib) Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Tagrisso (Osimertinib) Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Tagrisso (Osimertinib) Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Tagrisso (Osimertinib) Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Tagrisso (Osimertinib) Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Tagrisso (Osimertinib) Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Tagrisso (Osimertinib) Revenue Market Share by Country in 2021

Figure 58. Egypt Tagrisso (Osimertinib) Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Tagrisso (Osimertinib) Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Tagrisso (Osimertinib) Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Tagrisso (Osimertinib) Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Tagrisso (Osimertinib) Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Tagrisso (Osimertinib) in 2021

Figure 64. Manufacturing Process Analysis of Tagrisso (Osimertinib)

Figure 65. Industry Chain Structure of Tagrisso (Osimertinib)

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390